Goals of Project Sample Clauses

Goals of Project. The goals of the project are to materially improve the organic search engine results for the xxx.XXXXXXXXXXX.xxx website or other affiliated websites. The project will focus on approximately 10 targeted keyword phrases deemed valuable to the client in achieving internet traffic. To be noted is that achieving first page status for common usage keywords like “the internet” or “your Examples of targeted keywords: “your product” “your city, buying “your We would suggest creating a baseline traffic study using Google analytics to ascertain the progress of this project. This will also provide us with a critical feedback loop that will allow us to refine and re-target our campaign based on real time market demand data. To achieve search engine results we need to provide Google with the information they value in creating their ranking algorithms during their page spidering procedure. When the initial keywords list is developed we will use these terms to optimize your website site. This proposal includes the service provider search engine optimization formatting _6 pages of the clients web pages.  Title tags  Page descriptions  Meta tags descriptions  Alt tags  Content (keyword) seeding  Page breaks and word counts  Keyword allocation and density  Other techniques (including domain / keyword suggestions) The client will maintain full editorial control over the sites content but we will suggest techniques of “seeding” keywords is a manner that Google declares “relevant” when allocating page rank. To achieve satisfactory implementation, the project will require a cooperative relationship with the sites current webmaster to simply copy and paste our codes and data into each content page. If it should be determined that to complete the SEO project that direct access is required, then owner of the site must agree to hold Florida Website Marketing (Estate Settlement LLC holding company) harmless for any act. Google and other search engines have a simple and important goal to determine “relevance” and “importance” to web pages. They determine this from spidering other sites and finding relevant links back to your site. If a page has sufficient high quality links then Google and other search engines value the site higher in their organic search results. To achieve the desired results we will provide the following 150 Links:  135 anchor text links and 100 + word articles posted to blogs (the identity of these blogs is confidential).  15 anchor text links from our ...
Sample 1
AutoNDA by SimpleDocs
Goals of Project. Accelerating the clinical development of emetine hydrochloride for treatment of SARS-CoV-2 infection, including: Contributing to a review of the existing clinical experience with emetine for regulatory submissions Sharing materials, expertise and data that speed the generation of non-clinical safety and efficacy data to support clinical development goals Providing drug material and conducting a clinical proof of concept trial in patients with SARS-CoV-2 infection.
Sample 1
Goals of Project. The goal of this project is to create a sustainable supply of gentamicin in the Uniject™** device (hereafter called “gentamicin-Uniject”) so this innovative combination can be fully evaluated for use in the treatment of neonatal infections. The successful outcome of the screening and compatibility study of gentamicin-Uniject at BIOL, the private-sector collaborator in Argentina, coupled with the subsequent initiation of the formal stability study, has marked a major milestone in the progress of gentamicin-Uniject development. The outlook for technical feasibility is excellent, although a definitive conclusion necessarily awaits data from the formal stability study. ● The screening and compatibility study at BIOL was completed in December 2005. ● Frontage Laboratories’ analysis of gentamicin active pharmaceutical ingredient (API) from four different sources was completed in November. All four API manufacturers’ drug master files for gentamicin API are current with the USFDA. ● Results from the screening and compatibility study and the analysis of gentamicin API from different sources resulted in identification of two promising buffer systems, two promising API sources, and one alternate API source. ● The protocol and preparations for the formal stability study were completed, stability lot production undertaken, and the formal study initiated in March. PATH and BIOL collaboratively planned and reviewed the batch production, QC, and QA processes. ● The stability study start-up was postponed two months due to a delay by BD in shipping the Uniject devices to Argentina. As a result, filling of the Uniject devices by the contractor MR Xxxxxx had to be rescheduled from December 2005 to February 2006. ● BD, BIOL, and PATH have identified the source of confusion on the shipping documentation that lead to the delay. ● Three- and six-month time-point data from the formal stability study will be available. These time points will include data from gentamicin-Uniject stored under accelerated conditions. ● Pending positive stability study results, we will start planning production of a clinical trial lot of gentamicin-Uniject to meet the needs of any field studies requiring product in late 2006/2007 onward. ● PATH will assist BIOL in preparing a brief on manufacturing supply and cost of production scenario for gentamicin-Uniject. ● BIOL will initiate drafting of regulatory documentation for their application to the Argentine FDA for registration of gentamicin-Uniject. ● ...
Sample 1
Goals of Project. The goal of this project is to ensure that safe, appropriate, affordable applicators are available for use in low-resource settings at the time of microbicide introduction. In December 2005, HealthTech received a written response from the USFDA in regards to the pre- investigational new drug (IND) submission that we made in September 2005. This submission included a protocol for a “bridging study” for evaluating the equivalence between a user-filled paper applicator and a prefilled plastic applicator, as well as specific questions regarding the validity of this data for a sponsor’s new drug application to the FDA. Based on this response from the FDA, we are now proceeding with the two initial bridging studies set forth in the protocol. ● A collaboration agreement with Profamilia, our Dominican Republic clinical study partner, has been negotiated, and the clinical study protocol and data collection forms completed. This study will assess user compliance, acceptability, dose delivery, and safety of user-filled paper applicator with KY Jelly. ● A protocol for a comparative dose delivery study has been written and pretested, which will compare HTI prefilled and Tekpak user-filled applicators using hydroxyethyl cellulose (HEC) placebo. ● Prefilled applicators for the dose delivery study have been received through collaborations with XXXXXX and the International Program on Microbicides. User-filled applicators are ordered. ● A report on international manufacturers has been finalized and is available for dissemination. The study includes findings on an applicator manufacturers search in India and South Africa. ● A presentation on HealthTech applicator activities was made at the Alliance for Microbicide Development meeting in March 2006. This resulted in “delivery methods” being incorporated into the Microbicide Development Strategy which can hopefully highlight the importance of this topic among key donors and stakeholders. ● We were unsure of the appropriate multidose tube size to use for clinical study (of KY Jelly). After consulting with microbicide developers and researchers to get technical input, we assessed currently available tube sizes of KY Jelly and considered optimal multidose tube sizes for product introduction. Based on all factors, we decided to go with the tube holding 4 oz/124 ml of gel (approximately 35 doses at 3.5 ml/dose or 50 doses at 2.5 ml/dose). ● For the dosage delivery study, we need to repackage HEC placebo taken from surplus prefilled...
Sample 1
Goals of Project. The goal of the Project is to create a temporary funding mechanism to receive grants and disburse payment of expenses to support the initial establishment of the Pennsylvania Ag Discovery Center, established for the purpose above.
Sample 1
Goals of Project. The goal of this project is to create a sustainable supply of gentamicin in the Uniject™§ device (hereafter called “gentamicin-Uniject”) and to fully evaluate this innovative combination for use in the treatment of neonatal infections. BIOL of Argentina has produced gentamicin-Uniject to supply the Nepal Family Health Project (NFHP) evaluation in Nepal and will complete final packaging and shipment as soon as all required approvals in Nepal are granted. HealthTech and BIOL are working to develop and compile the data and expert opinion support for a submission by BIOL for Argentine FDA registration of gentamicin-Uniject. Field evaluation of gentamicin-Uniject in Nepal is on hold pending final approval from Nepalese authorities. • The proposal to field test gentamicin-Uniject in Nepal is undergoing review and approval by Nepalese authorities. Questions posed by the Nepal Health Research Council relating to the field evaluation were successfully addressed by Xxxxx Xxxxxxx at NFHP. • HealthTech initiated exploration of the option presented by Xxxxx Xxxx of the Society for Education Action and Research in Community Health (SEARCH) to use his India site for a cross-over comparison of syringe and needle versus gentamicin-Uniject. Mr. Xxxx is scaling up a newborn care package to sites for Maharashstra state (urban, rural, and tribal) to replicate the SEARCH newborn care model. Mr. Xxxx said the health workers would be ready to implement sepsis management in about nine months (summer 2008). • HealthTech will commission or facilitate expert drafting of a paper summarizing rationale and justification for the specific dosing indications for registration of gentamicin-Uniject. This will enable BIOL to complete regulatory documentation necessary for their application to the Argentine FDA for registration of gentamicin-Uniject, a key step on the path to eventual commercial availability. • BIOL will continue to complete stability studies, and to finalize and submit registration dossier. • HealthTech and BIOL will document resolution of critical technical feasibility issues for gentamicin- Uniject by submitting manuscript on compatibility/stability test results of the gentamicin-Uniject product for publication in a peer-reviewed journal. • We will monitor ongoing community-based studies designed to reduce neonatal mortality. • HealthTech will also monitor the international policy debate regarding possible change in standard treatment guidelines for neonatal sepsis (i.e., i...
Sample 1
Goals of Project. The goals of this project are to make an appropriate and affordable chlorhexidine (CHX) product for cleansing umbilical cords available in Nepal and to apply lessons learned in Nepal worldwide through the creation of a production development tool. A development and introduction plan of the CHX product into Bangladesh has been drafted and is currently being implemented by all relevant parties. CHX product development and introduction activities in Nepal are currently on hold pending decision by USAID stakeholders. • The final report of the Nepal-based manufacturer candidates including recommendation of most suitable partner was completed and disseminated to USAID. • A final report of the United States Food and Drug Administration (USFDA) CHX landscape analysis was submitted to USAID at the end of October 2007. • A joint site visit with PATH, Xxxxx Xxxxxxx University (JHU), and USAID to Bangladesh was conducted in February 2008. • PATH completed collaborative plans with JHU to develop and roll out a CHX product in Bangladesh which included determining the feasibility of pilot testing a small run of lotion product. • A scope of work (SOW) for Research, Training and Management International (RTM International) was developed and sent to USAID for comments. Follow up will be conducted with RTM via teleconference to confirm the SOW and negotiate an ongoing subagreement. • Criteria were developed for selecting a local manufacturer in Bangladesh. • A short list of manufacturer candidates in Bangladesh was created. • The list consists of 14 pharmaceutical companies in Bangladesh, including the top ten manufacturers in terms of revenue and four other manufacturers identified by the report that RTM International developed (“Assessment of the commercial private sector for health care products in Bangladesh”). A manufacturing proposal that includes market information, such as top-level demand projection and target market segments, was developed for Bangladesh. • A proposal was sent to the short list of manufacturers in Bangladesh to solicit their response/interest. Four companies (Beximco Pharmaceuticals, Acme Laboratories, Eskayef Bangladesh, and Popular Pharmaceutical) expressed their interest. • A list of potential marketing research partners in Bangladesh was created. • A SOW for a product attribute study in Bangladesh was developed. The RFP process for selecting a market research firm for this study in Sylhet was implemented. Two out of five companies that were sen...
Sample 1
AutoNDA by SimpleDocs
Goals of Project. The goals of this project are as follows: 1. Develop a viable synthetic route for the desired ERLs (Figure 8).
Sample 1

Related to Goals of Project

  • Completion of Project This Grant Agreement shall terminate upon completion of the project and payment of the last invoice.

  • Scope of Project i. The work to be per formed under the terms of this Agreement for the Rapid City Metropolitan Transportation Planning Process will be conducted in accordance with the CY 2019 Unified Planning Work Program incorporated in this Agreement by reference as Attachment D. ii. The Sub-Recipient’s Responsibilities:

  • Construction of Project 11.1.1 Developer agrees to cause the Project to be developed, constructed, and installed in accordance with the terms hereof and the Construction Provisions set forth in Exhibit D, including those things reasonably inferred from the Contract Documents as being within the scope of the Project and necessary to produce the stated result even though no mention is made in the Contract Documents.

  • Operating Budgets (i) The Borrowers shall, not later than thirty (30) days before the Commercial Operation Date for any Plant, adopt an Operating Budget with respect to such Plant and an updated aggregate Operating Budget for the Project from such date to the conclusion of the calendar year immediately following the then-current calendar year and provide a copy of such operating plan and budget at such time to the Administrative Agent. (ii) No less than sixty (60) days in advance of the beginning of each calendar year with respect to each Plant that has achieved its Commercial Operation Date, the Borrowers shall similarly adopt an operating plan and a budget setting forth in reasonable detail the projected requirements for Operation and Maintenance Expenses and Maintenance Capital Expenses for the ensuing two (2) calendar years for each Plant that has achieved its Commercial Operation Date and an aggregate operating plan and budget for the Project and provide a copy of each such operating plan and budget at such time to the Administrative Agent. (Each such operating plan and budget is herein called an "Operating Budget"). (iii) Each Operating Budget shall include the same items and detail as provided in the Financial Model and be prepared in accordance with a form similar to the Madera Operating Budget delivered on the Closing Date (or a form otherwise approved by the Administrative Agent) and shall become effective upon approval of the Administrative Agent (acting in consultation with the Consultants if the Administrative Agent reasonably determines that such consultation is necessary or desirable). The Administrative Agent's approval of such updated Operating Budgets shall not be unreasonably withheld or delayed. (iv) If the Borrowers have not adopted an annual Operating Budget covering the applicable two-year period for each Plant that has achieved its Commercial Operation Date and for the Project before the beginning of any calendar year following the Madera Funding or any Operating Budget adopted by the Borrowers has not been accepted by the Administrative Agent before the beginning of any upcoming calendar year, the Operating Budget for each relevant Plant for the preceding calendar year shall, until the adoption of an annual Operating Budget by the Borrowers and acceptance of such Operating Budget by the Administrative Agent, be deemed to be in force and effective as the annual Operating Budget for such Plant for such upcoming calendar year; provided that if the initial Operating Budget for any Plant is not approved by the Administrative Agent, the Borrowers may use a budget for such Plant that is consistent with the Financial Model until an initial Operating Budget is approved, and the Borrowers shall work diligently to prepare an initial Operating Budget for each Plant that is acceptable to the Administrative Agent. (v) If either the actual Operation and Maintenance Expenses or Maintenance Capital Expenses for any Fiscal Quarter is in excess of the applicable Permitted Operating Budget Deviation Levels, the Borrowers may deliver to the Administrative Agent and the Consultants a proposed updated Operating Budget(s), which shall be subject to approval by the Administrative Agent. Such proposed updated Operating Budget(s) shall not become effective until approved by the Administrative Agent. (vi) Each Operating Budget delivered to the Administrative Agent pursuant to this Section 7.01(j) shall be accompanied by a memorandum addressing all material deviations from the Financial Model.

  • DESCRIPTION OF PROJECT For the Company to be eligible to earn the Maximum Credit Amount, the Company will satisfy its obligations as reflected in the following representations, which the IEDC has relied upon: A. The Company will complete the Project at the Project Location. B. The Company represents that the number of permanent, Full-Time Employees (as defined in Indiana Code § 6–3.1–13–4) from whom Indiana state income tax withholdings are retained by the State of Indiana, employed as of the Commencement Date at the Project Location, is the Base Employment Number. C. The Project will result in the creation of New Employees (as defined in Indiana Code § 6- 3.1-13-6) at the Project Location of at least the Additional Jobs Commitment. D. The average of the hourly wages, before benefits, paid to New Employees at the Project Location, will at least equal the Average Wage Commitment. E. At the discretion of the IEDC, New Employees that are paid an average wage of less than the Minimum Wage Commitment may be excluded for the purpose of calculating the credit amount. F. The Project is anticipated to involve at least the Capital Investment Amount.

  • Description of Projects Services a. Project/Services to be performed by A-E shall consist of the work as specified herein and as required in Attachment A. If in the event Attachment A shall be in conflict with any provision of this Contract, the wording as set forth in Attachment A shall prevail. b. A-E shall be responsible for submitting all Projects/Services to County in a form which has been thoroughly reviewed and checked for completeness, accuracy and consistency by the registered professional named in Section 1.1.2 herein; and, any Projects/Services not meeting this requirement will be returned to A-E prior to review by County.

  • Operating Budget (a) No less than forty-five (45) days prior to the Substantial Completion of each train of the Project, and no less than forty-five (45) days prior to the beginning of each calendar year thereafter, the Borrower shall prepare a proposed operating plan and a budget setting forth in reasonable detail the projected requirements for Operation and Maintenance Expenses for the Borrower and the Project for the ensuing calendar year (or, in the case of the initial Operating Budget, the remaining portion thereof) and provide the Independent Engineer, the Common Security Trustee, and the Senior Facility Agent with a copy of such operating plan and budget (the “Operating Budget”). Each Operating Budget shall be prepared in accordance with a form approved by the Independent Engineer, shall set forth all material assumptions used in the preparation of such Operating Budget, and shall become effective upon approval of the Senior Facility Agent, acting reasonably and in consultation with the Independent Engineer; provided, that if the Senior Facility Agent shall not have approved or disapproved the Operating Budget within thirty (30) days after receipt thereof, such Operating Budget shall be deemed to have been approved; and provided, further that the Senior Facility Agent shall have neither the right nor the obligation to approve costs for Gas purchase contracts for the Project contained in the Operating Budget. If the Borrower does not have an effective annual Operating Budget before the beginning of any calendar year, until such proposed Operating Budget is approved, the Operating Budget most recently in effect shall continue to apply; provided, that (A) any items of the proposed Operating Budget that have been approved shall be given effect in substitution of the corresponding items in the Operating Budget most recently in effect, (B) costs for Gas purchase contracts for the Project shall be as provided by the Borrower and (C) all other items shall be increased by the lesser of (x) two and one-half percent (2.5%) and (y) the increase proposed by the Borrower for such item in such proposed Operating Budget. (b) Each Operating Budget delivered pursuant to this Section 1.12 shall contain Operating Budget Categories, and shall specify for each Fiscal Quarter and for each such Operating Budget Category the amount budgeted for such category for such Fiscal Quarter.

  • Payment of Project Activities County will reimburse Subrecipient for eligible project-related costs only. Subrecipient shall submit requests for reimbursement to County on a monthly basis beginning on August 1, 2021, and must provide adequate documentation as required by County in accordance with the OC Community Resources Contract Reimbursement Policy, as set forth in Exhibit 1, attached hereto and incorporated herein by reference. In addition, Subrecipient will provide a progress Grantee Performance Report (“GPR Information Form”) for the time period covered, as prescribed by County. Failure to provide any of the required documentation and reporting will cause County to withhold all or a portion of a request for reimbursement, or return the entire reimbursement package to Subrecipient, until such documentation and reporting has been received and approved by County.

  • Operating Plan To Agent and Lenders, as soon as available, but not later than thirty (30) days after the end of each Fiscal Year, an annual combined operating plan (the "Operating Plan") for Parent and its Subsidiaries, approved by the Board of Directors of Parent, for the following Fiscal Year, which (i) includes a statement of all of the material assumptions on which such plan is based, (ii) includes projected monthly income statement, balance sheets and source and use of funds for the following year and (iii) Borrowing Availability projections, all prepared on the same basis and in similar detail as that on which operating results are reported (and in the case of cash flow projections, representing management's good faith estimates of future financial performance based on historical performance), and including plans for personnel, Capital Expenditures and facilities.

  • Operation of Properties The Borrower will and will cause each Subsidiary to operate its Properties or cause such Properties to be operated in a careful and efficient manner in accordance with the practices of the industry and in compliance with all applicable contracts and agreements and in compliance in all material respects with all Governmental Requirements.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!